EUA
Simplexa COVID-19 Direct assay
FDA Emergency Use Authorization · DiaSorin Molecular LLC · Jul 22, 2021
Key facts
| Product | Simplexa COVID-19 Direct assay |
|---|---|
| Company | DiaSorin Molecular LLC |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Jul 22, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: